Perforomist
Showing 1 - 8 of 8
Pneumonia, Hypoxemia, Acute Respiratory Failure Trial in United States (Inhaled budesonide and formoterol, Inhaled )
Recruiting
- Pneumonia
- +3 more
- Inhaled budesonide and formoterol
- Inhaled placebo
-
Birmingham, Alabama
- +11 more
Aug 8, 2022
COPD (COPD) Trial in United States (Revefenacin, Placebo, Formoterol)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Revefenacin
- +2 more
-
Miami, Florida
- +11 more
Feb 22, 2022
COPD Exacerbation Trial in Knoxville (Revefenacin (YUPELRI) & Formoterol (Perforomist), Albuterol Inhalation Aerosol
Recruiting
- COPD Exacerbation
- Revefenacin (YUPELRI) & Formoterol (Perforomist)
- Albuterol Inhalation Aerosol (short-acting beta-agonists) & Ipratropium Aerosol (short-acting anticholinergic)
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Apr 26, 2021
COPD Exacerbation Trial in Knoxville (Formoterol, Placebo)
Completed
- COPD Exacerbation
- Formoterol
- Placebo
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Feb 28, 2019
COPD - COPD Trial in United States (Formoterol fumarate (6 µg), Formoterol furmarate (20 µg), Placebo for formoterol fumarate)
Completed
- Chronic Obstructive Pulmonary Disease - COPD
- Formoterol fumarate (6 μg)
- +4 more
-
Glendale, Arizona
- +19 more
Jan 11, 2018
COPD Trial in Greenville (Perforomist-Placebo, Perforomist, nebulization, COPD)
Completed
- COPD
- Perforomist-Placebo
- Perforomist, nebulization, COPD
-
Greenville, South CarolinaChandar Abboy
May 11, 2017
COPD, COPD, Chronic Bronchitis Trial in Los Angeles (formoterol fumarate)
Withdrawn
- Chronic Obstructive Pulmonary Disease
- +3 more
- formoterol fumarate
-
Los Angeles, CaliforniaUCLA David Geffen School of Medicine
Aug 2, 2016